Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA

CORC > 北京大学 > 生命科学学院

	Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
	Bai Yun ; Kan Shifeng ; Zhou Shixin ; Wang Yuting ; Xu Jun ; Cooke John P ; Wen Jinhua ; Deng Hongkui
刊名	Cell discovery
	2016
DOI	10.1038/celldisc.2015.52
英文摘要	[This corrects the article DOI: 10.1038/celldisc.2015.40.].; PubMed; 15052; 2
语种	英语
内容类型	期刊论文
源URL	[http://ir.pku.edu.cn/handle/20.500.11897/492904]
专题	生命科学学院
推荐引用方式 GB/T 7714	Bai Yun,Kan Shifeng,Zhou Shixin,et al. Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA[J]. Cell discovery,2016.
APA	Bai Yun.,Kan Shifeng.,Zhou Shixin.,Wang Yuting.,Xu Jun.,...&Deng Hongkui.(2016).Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA.Cell discovery.
MLA	Bai Yun,et al."Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA".Cell discovery (2016).